Mr. Damien McCallion:

I cannot comment on historical matters as I stepped into this role in recent weeks. I can come back to the Deputy on the history. We have seen what happened in CervicalCheck and the roll-out of open disclosure. It has not arisen in BowelScreen or diabetic retinopathy at this point. A plan has been in place that Professor O'Doherty has set out around the breast screening programme.

That is continuing and based on the experience of the only other jurisdiction in the European Union which has rolled it out. I suspect the primary reason it has taken that length of time since 2013 to do it is screening is different from normal day-to-day services and in order to roll it out it is clear from the experience in other countries such as England that it takes time to put it in place. The plan that has been developed is based on the experience in the only country in Europe which has rolled it out in screening programmes so far.